Authors:Sujit Bhattacharya, Shilpa, and Madhulika Bhati
technology but also in areas that are of pressing concerns in developing and improvised economies, i.e., environment, water purification, agriculture, energy and in a host of other products and services. For example in water treatment and re-use, engineered
there has been a steep rise in the demand for researches on it for various reasons.
Firstly, limitations of allopathic medicine, such as increased side effects, lack of curative treatment for several chronic diseases, high cost of new drugs
, tobacco consumption, to violence, substance use and disorder, to prophylaxis, treatment or to cancer risk, the new one is mainly devoted to HIV-related stigma, to social, socio-political and regional aspects of HIV, with one focus on AIDS in Africa
Authors:Dieter Vanderelst, Sara Speybroeck, and Niko Speybroeck
factors reflecting the neglect of these diseases is the attention paid by science to them. In this paper, we further evaluated the treatment of these conditions by the scientific community by investigating whether the perceived scientific impact of papers
showed marked increases in production which were related only to the special social position and social treatment they received. Thus, it was the ‘artificial’ social aspects of the experimental conditions set up for measurement which produced the
“quality” can be explained following the treatment of the subject by Waltman et al. ( 2011a , b ) Quality, when defined as an average, where complete bibliometric information is not available, is the ratio of total citations ( C ) to the number of papers
disciplines - a rather good point.
This treatment meets theoretical and practical limits. It is contingent to the delineation of disciplines—how subject categories are delineated—and to the granularity—the option of picking the subject categories 200
, when spinning off companies from universities and public research institutes was not common in Japan. Promotion measures are as follows: Approval of side jobs for RIKEN researchers, Preferential treatment of spin-off companies in joint R&D (e.g. free